Heshu Liu

737 total citations
17 papers, 464 citations indexed

About

Heshu Liu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Heshu Liu has authored 17 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Heshu Liu's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers) and Cancer-related gene regulation (4 papers). Heshu Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers) and Cancer-related gene regulation (4 papers). Heshu Liu collaborates with scholars based in China. Heshu Liu's co-authors include Yang Ge, Hang Zheng, Xin Wang, Jian Liu, Huayu Li, Rui Yan, Jiannan Yao, Xiaona Fan, Guangyu An and Tao Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cancer Letters and BioMed Research International.

In The Last Decade

Heshu Liu

17 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heshu Liu China 13 235 216 138 122 115 17 464
Marco Zanotto Italy 9 221 0.9× 254 1.2× 85 0.6× 118 1.0× 134 1.2× 13 489
Leili Saeednejad Zanjani Iran 13 273 1.2× 201 0.9× 102 0.7× 114 0.9× 74 0.6× 37 497
Zehua Wang China 13 275 1.2× 185 0.9× 103 0.7× 187 1.5× 126 1.1× 32 562
Katsuharu Saito Japan 13 256 1.1× 208 1.0× 83 0.6× 112 0.9× 159 1.4× 26 476
Zhuqing Zhou China 14 329 1.4× 150 0.7× 97 0.7× 205 1.7× 66 0.6× 26 529
Kelly E. Craven United States 9 233 1.0× 204 0.9× 61 0.4× 125 1.0× 61 0.5× 15 441
Joseph Clara United States 6 356 1.5× 317 1.5× 76 0.6× 186 1.5× 153 1.3× 12 638
Raefa Abou Khouzam France 12 201 0.9× 179 0.8× 87 0.6× 224 1.8× 148 1.3× 21 501
Shuier Zheng China 13 269 1.1× 144 0.7× 110 0.8× 109 0.9× 94 0.8× 31 431

Countries citing papers authored by Heshu Liu

Since Specialization
Citations

This map shows the geographic impact of Heshu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heshu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heshu Liu more than expected).

Fields of papers citing papers by Heshu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heshu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heshu Liu. The network helps show where Heshu Liu may publish in the future.

Co-authorship network of co-authors of Heshu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Heshu Liu. A scholar is included among the top collaborators of Heshu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heshu Liu. Heshu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Heshu, et al.. (2025). Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma. Cancer Medicine. 14(2). e70605–e70605. 2 indexed citations
2.
3.
Yan, Rui, et al.. (2023). Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis. Cancer Prevention Research. 16(12). 669–679. 8 indexed citations
4.
5.
6.
Zheng, Hang, Heshu Liu, Huayu Li, et al.. (2022). Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. Stem Cell Research & Therapy. 13(1). 244–244. 79 indexed citations
7.
Liu, Heshu, Xiaona Fan, Rui Yan, et al.. (2022). A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer. Cancer Gene Therapy. 30(1). 192–208. 13 indexed citations
8.
Yan, Rui, Jian Jian Li, Xiaona Fan, et al.. (2022). DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis. Cellular and Molecular Gastroenterology and Hepatology. 15(2). 463–485. 18 indexed citations
9.
Ge, Yang, Heshu Liu, Yuanyuan Zhang, et al.. (2022). Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Translational Oncology. 17. 101317–101317. 17 indexed citations
10.
Yan, Rui, Xiaona Fan, Heshu Liu, et al.. (2022). Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness. Cancer Letters. 531. 83–97. 41 indexed citations
11.
12.
Fan, Shanshan, Yang Ge, Jian Liu, et al.. (2021). Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro. Journal of Clinical Laboratory Analysis. 35(10). e23986–e23986. 20 indexed citations
13.
14.
Yao, Jiannan, Ling Duan, Jian Liu, et al.. (2021). Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 769727–769727. 22 indexed citations
15.
Wen, Tao, Yang Ge, Jian Liu, et al.. (2019). Disruption of Core 1-mediated O-glycosylation oppositely regulates CD44 expression in human colon cancer cells and tumor-derived exosomes. Biochemical and Biophysical Research Communications. 521(2). 514–520. 25 indexed citations
16.
Liu, Heshu, Tao Wen, Xiaona Fan, et al.. (2019). DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells. BioMed Research International. 2019. 1–8. 32 indexed citations
17.
Liu, Qun, Heshu Liu, Lina Li, et al.. (2019). ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation. International Journal of Oncology. 56(1). 219–231. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Zanotto Breakdown of academic impact, for papers by Leili Saeednejad Zanjani Breakdown of academic impact, for papers by Zehua Wang Breakdown of academic impact, for papers by Katsuharu Saito Breakdown of academic impact, for papers by Zhuqing Zhou Breakdown of academic impact, for papers by Kelly E. Craven Breakdown of academic impact, for papers by Joseph Clara Breakdown of academic impact, for papers by Raefa Abou Khouzam Breakdown of academic impact, for papers by Shuier Zheng
Rankless by CCL
2026